Valeant Takes Another Step Toward $53B Allergan Deal
Valeant Pharmaceuticals International Inc. continued to bear down on its hostile pursuit of Allergan Inc., saying Wednesday it would seek investor approval for a share issue to help cover its activist-backed...To view the full article, register now.
Already a subscriber? Click here to view full article